{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:31:47Z","timestamp":1785461507987,"version":"3.56.0"},"reference-count":12,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1080\/21645515.2016.1212145","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T22:06:43Z","timestamp":1469484403000},"page":"3099-3102","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Crucial requirement for standardization during the development of novel recombinant BCG vaccines: Does the corresponding substrain background matter?"],"prefix":"10.1080","volume":"12","author":[{"given":"P. R. Z.","family":"Antas","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Imunologia Cl\u00ednica, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,7,25]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00277-1"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.2.708-716.2003"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1086\/314073"},{"issue":"5","key":"cit0004","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1128\/IAI.66.5.2221-2229.1998","volume":"66","author":"Brosch R","year":"1998","journal-title":"Infect Immun"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.03.014"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.11.026"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.07.087"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.2.708-716.2003"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036198"},{"key":"cit0010","first-page":"107","volume":"21","author":"Lotte A","year":"1984","journal-title":"Adv Tuberc Res"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2011.11.004"},{"key":"cit0012","first-page":"65","volume":"43","author":"Bunch-Christensen K","year":"1970","journal-title":"Bull World Health Organ"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2016.1212145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:52:55Z","timestamp":1600937575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2016.1212145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,25]]},"references-count":12,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,23]]},"published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1080\/21645515.2016.1212145"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2016.1212145","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}